Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 8.28
(-0.12%)
CNY 8.28
(-0.12%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.08 Billion CNY | -13.32% |
| 2022 | 1.27 Billion CNY | -10.58% |
| 2021 | 1.42 Billion CNY | 22.07% |
| 2020 | 1.16 Billion CNY | 5.67% |
| 2019 | 1.1 Billion CNY | 14.99% |
| 2018 | 957.77 Million CNY | 6.68% |
| 2017 | 897.84 Million CNY | 20.98% |
| 2016 | 742.16 Million CNY | 8.56% |
| 2015 | 683.67 Million CNY | 7.59% |
| 2014 | 635.46 Million CNY | 7.24% |
| 2013 | 592.57 Million CNY | 18.39% |
| 2012 | 500.51 Million CNY | 15.23% |
| 2011 | 434.36 Million CNY | 34.08% |
| 2010 | 323.95 Million CNY | 39.29% |
| 2009 | 232.57 Million CNY | 21.03% |
| 2008 | 192.16 Million CNY | 9.88% |
| 2007 | 174.89 Million CNY | 40.06% |
| 2006 | 124.86 Million CNY | 21.98% |
| 2005 | 102.37 Million CNY | -41.01% |
| 2004 | 173.52 Million CNY | 63.45% |
| 2003 | 106.16 Million CNY | 10.44% |
| 2002 | 96.12 Million CNY | 58.58% |
| 2001 | 60.61 Million CNY | 17.76% |
| 2000 | 51.47 Million CNY | -26.69% |
| 1999 | 70.21 Million CNY | 7.55% |
| 1998 | 65.28 Million CNY | 28.95% |
| 1997 | 50.62 Million CNY | 6.59% |
| 1996 | 47.49 Million CNY | -23.31% |
| 1995 | 61.93 Million CNY | 33252.0% |
| 1994 | 185.7 Thousand CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 410.32 Million CNY | 0.2% |
| 2024 Q1 | 247.2 Million CNY | -26.73% |
| 2024 Q2 | 356.49 Million CNY | 44.21% |
| 2023 Q3 | 295.95 Million CNY | 5.2% |
| 2023 Q2 | 281.31 Million CNY | 13.98% |
| 2023 Q4 | 337.39 Million CNY | 14.0% |
| 2023 FY | 1.1 Billion CNY | -13.32% |
| 2023 Q1 | 246.81 Million CNY | -25.63% |
| 2022 Q1 | 290.16 Million CNY | -27.91% |
| 2022 Q3 | 325.26 Million CNY | 0.67% |
| 2022 Q4 | 331.86 Million CNY | 2.03% |
| 2022 Q2 | 323.09 Million CNY | 11.35% |
| 2022 FY | 1.27 Billion CNY | -10.58% |
| 2021 Q1 | 295.52 Million CNY | -4.4% |
| 2021 Q2 | 332.49 Million CNY | 12.51% |
| 2021 Q3 | 390.18 Million CNY | 17.35% |
| 2021 Q4 | 402.47 Million CNY | 3.15% |
| 2021 FY | 1.42 Billion CNY | 22.07% |
| 2020 Q4 | 309.11 Million CNY | -3.06% |
| 2020 Q2 | 289.55 Million CNY | 17.56% |
| 2020 Q1 | 246.3 Million CNY | -31.4% |
| 2020 FY | 1.16 Billion CNY | 5.67% |
| 2020 Q3 | 318.88 Million CNY | 10.13% |
| 2019 Q4 | 359.07 Million CNY | 27.73% |
| 2019 FY | 1.1 Billion CNY | 14.99% |
| 2019 Q3 | 281.11 Million CNY | 15.73% |
| 2019 Q1 | 218.29 Million CNY | -30.85% |
| 2019 Q2 | 242.89 Million CNY | 11.27% |
| 2018 Q3 | 194.51 Million CNY | -16.29% |
| 2018 FY | 957.77 Million CNY | 6.68% |
| 2018 Q4 | 315.7 Million CNY | 62.3% |
| 2018 Q1 | 215.18 Million CNY | -26.33% |
| 2018 Q2 | 232.37 Million CNY | 7.99% |
| 2017 Q4 | 292.1 Million CNY | 36.88% |
| 2017 Q2 | 213.41 Million CNY | 19.27% |
| 2017 FY | 897.84 Million CNY | 20.98% |
| 2017 Q1 | 178.92 Million CNY | -29.65% |
| 2017 Q3 | 213.4 Million CNY | -0.0% |
| 2016 Q3 | 193.46 Million CNY | 37.02% |
| 2016 Q1 | 153.18 Million CNY | -25.17% |
| 2016 FY | 742.16 Million CNY | 8.56% |
| 2016 Q4 | 254.32 Million CNY | 31.46% |
| 2016 Q2 | 141.19 Million CNY | -7.83% |
| 2015 FY | 683.67 Million CNY | 7.59% |
| 2015 Q4 | 204.71 Million CNY | 9.13% |
| 2015 Q3 | 187.58 Million CNY | 25.42% |
| 2015 Q2 | 149.56 Million CNY | 5.47% |
| 2015 Q1 | 141.8 Million CNY | -23.43% |
| 2014 Q4 | 185.19 Million CNY | 7.01% |
| 2014 FY | 635.46 Million CNY | 7.24% |
| 2014 Q1 | 126.96 Million CNY | -47.07% |
| 2014 Q2 | 150.23 Million CNY | 18.33% |
| 2014 Q3 | 173.06 Million CNY | 15.2% |
| 2013 Q2 | 123.84 Million CNY | 14.49% |
| 2013 Q3 | 120.72 Million CNY | -2.52% |
| 2013 FY | 592.57 Million CNY | 18.39% |
| 2013 Q4 | 239.84 Million CNY | 98.67% |
| 2013 Q1 | 108.16 Million CNY | -44.72% |
| 2012 Q2 | 110.16 Million CNY | 23.52% |
| 2012 Q3 | 105.5 Million CNY | -4.23% |
| 2012 Q4 | 195.65 Million CNY | 85.44% |
| 2012 FY | 500.51 Million CNY | 15.23% |
| 2012 Q1 | 89.18 Million CNY | -44.88% |
| 2011 Q4 | 161.82 Million CNY | 36.24% |
| 2011 Q1 | 63.3 Million CNY | -49.75% |
| 2011 Q2 | 90.46 Million CNY | 42.92% |
| 2011 Q3 | 118.77 Million CNY | 31.29% |
| 2011 FY | 434.36 Million CNY | 34.08% |
| 2010 Q4 | 125.97 Million CNY | 57.81% |
| 2010 Q2 | 69.48 Million CNY | 42.75% |
| 2010 FY | 323.95 Million CNY | 39.29% |
| 2010 Q1 | 48.67 Million CNY | -51.06% |
| 2010 Q3 | 79.82 Million CNY | 14.89% |
| 2009 Q4 | 99.44 Million CNY | 63.38% |
| 2009 Q2 | 35.48 Million CNY | -3.55% |
| 2009 Q1 | 36.78 Million CNY | -54.54% |
| 2009 FY | 232.57 Million CNY | 21.03% |
| 2009 Q3 | 60.86 Million CNY | 71.54% |
| 2008 FY | 192.16 Million CNY | 9.88% |
| 2008 Q4 | 80.92 Million CNY | 118.16% |
| 2008 Q3 | 37.09 Million CNY | -14.6% |
| 2008 Q1 | 30.71 Million CNY | -57.72% |
| 2008 Q2 | 43.43 Million CNY | 41.39% |
| 2007 Q2 | 40.67 Million CNY | 62.48% |
| 2007 Q3 | 36.53 Million CNY | -10.19% |
| 2007 FY | 174.89 Million CNY | 40.06% |
| 2007 Q4 | 72.65 Million CNY | 98.89% |
| 2007 Q1 | 25.03 Million CNY | -64.48% |
| 2006 Q4 | 70.48 Million CNY | 221.82% |
| 2006 Q1 | 18.95 Million CNY | -57.31% |
| 2006 Q3 | 21.9 Million CNY | 61.9% |
| 2006 FY | 124.86 Million CNY | 21.98% |
| 2006 Q2 | 13.52 Million CNY | -28.63% |
| 2005 Q2 | 20.41 Million CNY | 43.94% |
| 2005 Q1 | 14.18 Million CNY | -87.63% |
| 2005 Q3 | 23.36 Million CNY | 14.45% |
| 2005 Q4 | 44.39 Million CNY | 89.97% |
| 2005 FY | 102.37 Million CNY | -41.01% |
| 2004 Q2 | 20.83 Million CNY | 29.8% |
| 2004 FY | 173.52 Million CNY | 63.45% |
| 2004 Q4 | 114.7 Million CNY | 422.69% |
| 2004 Q3 | 21.94 Million CNY | 5.34% |
| 2004 Q1 | 16.04 Million CNY | -60.53% |
| 2003 Q2 | 24.23 Million CNY | 29.36% |
| 2003 Q3 | 22.53 Million CNY | -7.05% |
| 2003 Q4 | 40.65 Million CNY | 80.45% |
| 2003 FY | 106.16 Million CNY | 10.44% |
| 2003 Q1 | 18.73 Million CNY | -47.01% |
| 2002 Q4 | 35.35 Million CNY | 58.63% |
| 2002 Q3 | 22.28 Million CNY | -0.94% |
| 2002 Q1 | 15.98 Million CNY | 0.0% |
| 2002 FY | 96.12 Million CNY | 58.58% |
| 2002 Q2 | 22.49 Million CNY | 40.79% |
| 2001 FY | 60.61 Million CNY | 17.76% |
| 2000 FY | 51.47 Million CNY | -26.69% |
| 1999 FY | 70.21 Million CNY | 7.55% |
| 1998 FY | 65.28 Million CNY | 28.95% |
| 1997 FY | 50.62 Million CNY | 6.59% |
| 1996 FY | 47.49 Million CNY | -23.31% |
| 1995 FY | 61.93 Million CNY | 33252.0% |
| 1994 FY | 185.7 Thousand CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 14.38 Billion CNY | 92.427% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.3 Billion CNY | 16.821% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.14 Billion CNY | 65.408% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.08 Billion CNY | -0.298% |
| Aurora Optoelectronics Co.,Ltd. | 482.31 Million CNY | -125.842% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 64.1 Million CNY | -1599.3% |
| NanJing Pharmaceutical Company Limited | 2.3 Billion CNY | 52.76% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 818.48 Million CNY | -33.085% |